Prevalence and Significance of Antinuclear Antibodies in Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Figure 2

Overall prevalence of antinuclear antibody positivity in biopsy-proven NAFLD. ANA: antinuclear antibody.